Current Opinion in Obstetrics and Gynecology was launched in 1989. It is one of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The field of obstetrics and gynecology is divided into nine sections that are reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Journal's Editor and Section Editor for this issue.
Jonathan S. Berek
Dr Berek is a Professor at Stanford University School of Medicine, where he is the Chair of the Department of Obstetrics and Gynecology, and the Chief of Obstetrics and Gynecology at the Stanford University Hospital and Clinics. He is also Co-Director, Women's Cancer Program, Standford Cancer Centre.
Dr Berek is well known as a pelvic surgeon, gynecologic oncologist and gynecologist. He is highly regarded for his research on the clinical management of gynecologic cancers and translational research related to these malignancies. He has published over 400 research papers, book chapters and monographs. He is especially noted for his popular books, ‘Practical Gynecologic Oncology’ and ‘Berek & Novak's Gynecology’.
Dr Berek earned his undergraduate degree from Brown, his doctor of medicine degree at Johns Hopkins University School of Medicine, completed his residency at Harvard Medical School and the Brigham and Women's Hospital, and gained his fellowship in gynecologic oncology at the UCLA School of Medicine. For many years, he was a Professor at UCLA, where he was also the Chair of the College of Applied Anatomy.
His primary research interests are in the immunology and immunotherapy of ovarian cancer and the development of experimental models and clinical trials. His research team's initial work with the use of intraperitoneal biologic response modifiers, especially interferons and interleukins, encouraged the development of biologic therapy strategies. He is the Group Chair and Principal Investigator for the Cooperative Ovarian Cancer Group for Immunotherapy (COGI). Through collaborative work, his team is focusing on the development of monoclonal antibodies and novel strategies for the treatment of ovarian cancer. He is Principal Investigator for the Gynecologic Oncology Group (GOG). Dr Berek has grant support from the National Cancer Institute (NCI) and the Ovarian Cancer Research Foundation (OCRF).
He also is regularly listed among America's Best Doctors for Gynecology & Gynecologic Oncology. He is the recipient of the prestigious Sherman Mellinkoff Award and the Excellence in Education Award by the David Geffen School of Medicine at UCLA.
He is board certified by the American Board of Obstetrics and Gynecology (ABOG) and the Division of Gynecologic Oncology. He is a Fellow in the American College of Obstetricians and Gynecologists (FACOG) and in the American College of Surgeons (FACS). Dr Berek has served as an examiner for the American Board of Obstetrics & Gynecology (ABOG) and for the Council on Resident Education in Obstetrics and Gynecology (CREOG).
Dr Berek's many honors include receiving the President's Award from the Society of Gynecologic Oncologists (SGO), serving as its Vice President in 1996–1997, and presenting numerous distinguished lectureships. Dr Berek has served on many national committees including the Clinical Cancer Programs Review Committees, and for the American College of Obstetricians and Gynecologists (ACOG). He is also an active member of the Society of Gynecologic Investigation (SGI) and the Society of Pelvic Surgeons. Dr Berek is President-elect of the International Gynecologic Cancer Society (IGCS), 2008–2010.
He is an Editor of Prolog and Précis for the American College of Obstetricians and Gynecologists. He is the Editor in Chief of Current Problems in Obstetrics and Gynecology, ASCO News & Forum, and a Senior Editor of the International Journal of Gynecologic Cancer, and has served on the editorial boards of the Journal of Clinical Oncology, Gynecologic Oncology, and the Journal of the Society for Gynecologic Investigation. He serves as a reviewer for Obstetrics & Gynecology, American Journal of Obstetrics and Gynecology, New England Journal of Medicine, Lancet, Cancer, and Journal of the National Cancer Institute, among others.
Anne O. Rodriguez
Dr Rodriguez received her medical and undergraduate degrees with honors at Northwestern University and completed her residency in Obstetrics and Gynecology at the University of North Carolina at Chapel Hill. She then completed a three year fellowship in Gynecologic Oncology at the University of Miami/Jackson Memorial Hospital. She is currently Assistant Professor of clinical Obstetrics and Gynecology at the University of California, Davis, School of Medicine and also maintains an active clinical practice in gynecologic oncology. She is assistant fellowship program director for the UCDavis fellowship in gynecologic oncology and is active in multiple research endeavors. She currently serves on multiple local committees and at the national level in the Patient Education committee of the American College of Obstetricians and Gynecologists. She has a special interest in complementary medicine and is trained in medical acupuncture.